Mr. Caplan is one of five attorneys nationwide to be recognized as a 2013 MVP in the area of Private Equity.
Willkie partner Gordon Caplan was profiled as part of Law360’s MVP series, which features "elite law firm partners" in recognition of their "exemplary work" on "mammoth deals and first-of-their-kind global matters." After a formal nomination and selection process conducted by a team of Law 360 editors, involving hundreds of candidates, Mr. Caplan was one of only five attorneys nationwide to be named MVP in the area of Private Equity.
The profile, published on December 12, praises Mr. Caplan for "working on some of this year's most complex, uniquely structured private equity deals," including Hudson's Bay Co.'s $2.9 billion leveraged take-private acquisition of Saks Inc., and the sale of private equity-backed Pearl Therapeutics to AstraZeneca PLC for $1.15 billion.
The article also includes an interview with Mr. Caplan, who noted that the Hudson's Bay-Saks deal was among his most complex of the year, involving a wide array of private equity disciplines. He felt it was particularly fun because it was a cross-border leveraged acquisition of a global icon involving both full equity financing and debt financing for a major retail operating company.
Read: Private Equity MVP: Willkie's Gordon Caplan